id	sid	eid	entity	type
dpc-4893	3	1	2025;15(1):4893 1	CARDINAL
dpc-4893	3	2	27	CARDINAL
dpc-4893	3	3	24-week	DATE
dpc-4893	3	4	zeno fratton1	ORG
dpc-4893	3	5	vincenzo maione2	PERSON
dpc-4893	3	6	bighetti2	PERSON
dpc-4893	3	7	bettolini2	GPE
dpc-4893	3	8	stinco1	PERSON
dpc-4893	3	9	errichetti1 1 institute of dermatology	ORG
dpc-4893	3	10	university of udine	ORG
dpc-4893	3	11	italy 2	ORG
dpc-4893	3	12	brescia	GPE
dpc-4893	3	13	asst spedali civili di brescia	PERSON
dpc-4893	3	14	brescia	GPE
dpc-4893	3	15	italy	GPE
dpc-4893	3	16	bimekizumab	PERSON
dpc-4893	3	17	maione v	PERSON
dpc-4893	3	18	bighetti s	PERSON
dpc-4893	3	19	27	CARDINAL
dpc-4893	3	20	24-week	DATE
dpc-4893	5	1	2025;15(1):4893	PERSON
dpc-4893	6	1	https://doi.org/10.5826/	ORG
dpc-4893	6	2	september 30, 2024	DATE
dpc-4893	7	1	january 2025	DATE
dpc-4893	7	2	2024	CARDINAL
dpc-4893	8	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-4893	12	1	zeno fratton	PERSON
dpc-4893	12	2	md, institute of dermatology	ORG
dpc-4893	12	3	piazzale	GPE
dpc-4893	12	4	santa maria	GPE
dpc-4893	12	5	della misericordia	PERSON
dpc-4893	12	6	15	CARDINAL
dpc-4893	12	7	33100	DATE
dpc-4893	12	8	udine	GPE
dpc-4893	12	9	italy	GPE
dpc-4893	13	1	+39) 0432559822	DATE
dpc-4893	15	1	1-4	CARDINAL
dpc-4893	16	1	around 25%	PERCENT
dpc-4893	16	2	1-5].1	CARDINAL
dpc-4893	16	3	il-17a	PRODUCT
dpc-4893	16	4	6	CARDINAL
dpc-4893	17	1	24-week	DATE
dpc-4893	17	2	2	CARDINAL
dpc-4893	17	3	italian	NORP
dpc-4893	17	4	udine	PERSON
dpc-4893	17	5	brescia	PERSON
dpc-4893	18	1	10	CARDINAL
dpc-4893	18	2	24-week	DATE
dpc-4893	20	1	4, week 16 and week 24	DATE
dpc-4893	20	2	90	CARDINAL
dpc-4893	20	3	100	CARDINAL
dpc-4893	21	1	aes	ORG
dpc-4893	22	1	2	CARDINAL
dpc-4893	25	1	helsinki	ORG
dpc-4893	26	1	27	CARDINAL
dpc-4893	26	2	12.1 years	DATE
dpc-4893	26	3	33.4 ± 3.6 kg/m2	QUANTITY
dpc-4893	27	1	16.9 ±	CARDINAL
dpc-4893	27	2	8.8 years	DATE
dpc-4893	28	1	13.3 ± 8.2	QUANTITY
dpc-4893	28	2	74.1%	PERCENT
dpc-4893	28	3	at least 1	CARDINAL
dpc-4893	28	4	40.7%	PERCENT
dpc-4893	29	1	81.5%	PERCENT
dpc-4893	29	2	at least 1	CARDINAL
dpc-4893	29	3	66.7%	PERCENT
dpc-4893	29	4	at least 1	CARDINAL
dpc-4893	30	1	40.7%	PERCENT
dpc-4893	31	1	1	CARDINAL
dpc-4893	32	1	13.3 ± 8.1	QUANTITY
dpc-4893	32	2	2.3 ± 2.4	MONEY
dpc-4893	32	3	week 4	DATE
dpc-4893	32	4	1.0 ± 1.7	QUANTITY
dpc-4893	32	5	week 16	DATE
dpc-4893	32	6	0.6 ± 1.5	MONEY
dpc-4893	32	7	week 24	DATE
dpc-4893	32	8	1	CARDINAL
dpc-4893	33	1	pasi90	ORG
dpc-4893	33	2	week 4	DATE
dpc-4893	33	3	74.1%	PERCENT
dpc-4893	33	4	pasi90	ORG
dpc-4893	33	5	37.0%	PERCENT
dpc-4893	33	6	25.9%	PERCENT
dpc-4893	33	7	week 16	DATE
dpc-4893	33	8	88.9%	PERCENT
dpc-4893	33	9	pasi90	ORG
dpc-4893	33	10	70.4%	PERCENT
dpc-4893	33	11	55.6%	PERCENT
dpc-4893	33	12	week 24	DATE
dpc-4893	33	13	96.3%	PERCENT
dpc-4893	33	14	pasi90	ORG
dpc-4893	33	15	85.2%	PERCENT
dpc-4893	33	16	74.1%	PERCENT
dpc-4893	34	1	only 1	CARDINAL
dpc-4893	34	2	3.7%	PERCENT
dpc-4893	34	3	week 12	DATE
dpc-4893	34	4	aes	ORG
dpc-4893	34	5	aes	ORG
dpc-4893	35	1	24-week	DATE
dpc-4893	36	1	20 and 23	CARDINAL
dpc-4893	37	1	week 24 pasi75	DATE
dpc-4893	37	2	pasi90	ORG
dpc-4893	37	3	88.07%	PERCENT
dpc-4893	37	4	74.31%	PERCENT
dpc-4893	37	5	53.32%	PERCENT
dpc-4893	37	6	week 24 pasi75	DATE
dpc-4893	37	7	pasi90	ORG
dpc-4893	37	8	89.5%	PERCENT
dpc-4893	37	9	73.3%	PERCENT
dpc-4893	37	10	50%	PERCENT
dpc-4893	37	11	risankizumab	PERSON
dpc-4893	37	12	week 16	DATE
dpc-4893	37	13	pasi90	ORG
dpc-4893	37	14	66%	PERCENT
dpc-4893	37	15	40%	PERCENT
dpc-4893	37	16	28%	PERCENT
dpc-4893	37	17	week 28	DATE
dpc-4893	37	18	pasi90	ORG
dpc-4893	37	19	87%	PERCENT
dpc-4893	37	20	72%	PERCENT
dpc-4893	37	21	58%	PERCENT
dpc-4893	37	22	1-4	CARDINAL
dpc-4893	39	1	1	CARDINAL
dpc-4893	39	2	27 age, years	DATE
dpc-4893	39	3	50.0 ± 12.1	QUANTITY
dpc-4893	39	4	19	CARDINAL
dpc-4893	39	5	70.4%	PERCENT
dpc-4893	39	6	33.4 ±	CARDINAL
dpc-4893	39	7	3.6	CARDINAL
dpc-4893	39	8	16.9 ± 8.8 psoriasis	QUANTITY
dpc-4893	39	9	10	CARDINAL
dpc-4893	39	10	37.0%	PERCENT
dpc-4893	39	11	n (%) 5 (	ORG
dpc-4893	39	12	18.5%	PERCENT
dpc-4893	39	13	5.2 ±	QUANTITY
dpc-4893	39	14	20 (74.1%	PERCENT
dpc-4893	39	15	12	DATE
dpc-4893	39	16	44.4%	PERCENT
dpc-4893	39	17	13	DATE
dpc-4893	39	18	48.1%	PERCENT
dpc-4893	39	19	4	DATE
dpc-4893	39	20	14.8%	PERCENT
dpc-4893	39	21	11	DATE
dpc-4893	39	22	40.7%	PERCENT
dpc-4893	39	23	13.3 ±	MONEY
dpc-4893	39	24	n (%	PERCENT
dpc-4893	39	25	11	CARDINAL
dpc-4893	39	26	40.7%	PERCENT
dpc-4893	39	27	9	DATE
dpc-4893	39	28	33.3%	PERCENT
dpc-4893	39	29	4	DATE
dpc-4893	39	30	14.8%	PERCENT
dpc-4893	39	31	2	CARDINAL
dpc-4893	39	32	7.4%	PERCENT
dpc-4893	39	33	n (%	PERCENT
dpc-4893	39	34	phototherapy	ORG
dpc-4893	39	35	acitretin 22	PERSON
dpc-4893	39	36	81.5%	PERCENT
dpc-4893	39	37	11	DATE
dpc-4893	39	38	40.7%	PERCENT
dpc-4893	39	39	10	CARDINAL
dpc-4893	39	40	37.0%	PERCENT
dpc-4893	39	41	10	CARDINAL
dpc-4893	39	42	37.0%	PERCENT
dpc-4893	39	43	7	DATE
dpc-4893	39	44	25.9%	PERCENT
dpc-4893	39	45	adalimumab secukinumab ustekinumab guselkumab ixekizumab brodalumab etanercept	PERSON
dpc-4893	39	46	risankizumab	PERSON
dpc-4893	39	47	18	DATE
dpc-4893	39	48	66.7%	PERCENT
dpc-4893	39	49	9	DATE
dpc-4893	39	50	33.3%	PERCENT
dpc-4893	39	51	13	DATE
dpc-4893	39	52	48.1%	PERCENT
dpc-4893	39	53	7	DATE
dpc-4893	39	54	25.9%	PERCENT
dpc-4893	39	55	4	DATE
dpc-4893	39	56	14.8%	PERCENT
dpc-4893	39	57	2	CARDINAL
dpc-4893	39	58	7.4%	PERCENT
dpc-4893	39	59	2	CARDINAL
dpc-4893	39	60	7.4%	PERCENT
dpc-4893	39	61	1	CARDINAL
dpc-4893	39	62	3.7%	PERCENT
dpc-4893	39	63	1	CARDINAL
dpc-4893	39	64	3.7%	PERCENT
dpc-4893	39	65	1	CARDINAL
dpc-4893	39	66	3.7%	PERCENT
dpc-4893	39	67	1	CARDINAL
dpc-4893	39	68	3.7%	PERCENT
dpc-4893	39	69	1	CARDINAL
dpc-4893	39	70	3.7%	PERCENT
dpc-4893	39	71	n (%	ORG
dpc-4893	39	72	1	CARDINAL
dpc-4893	39	73	2	CARDINAL
dpc-4893	39	74	3	CARDINAL
dpc-4893	39	75	10	CARDINAL
dpc-4893	39	76	37.0%	PERCENT
dpc-4893	39	77	2	CARDINAL
dpc-4893	39	78	14.8%	PERCENT
dpc-4893	39	79	2	CARDINAL
dpc-4893	39	80	14.8%	PERCENT
dpc-4893	39	81	1 (	PERCENT
dpc-4893	39	82	3.7%	PERCENT
dpc-4893	39	83	1	CARDINAL
dpc-4893	39	84	3.7%	PERCENT
dpc-4893	39	85	w	ORG
dpc-4893	43	1	2025;15(1):4893 3	DATE
dpc-4893	45	1	1	CARDINAL
dpc-4893	45	2	megna m	PERSON
dpc-4893	45	3	di costanzo l	PERSON
dpc-4893	45	4	italian	NORP
dpc-4893	45	5	84 week	DATE
dpc-4893	46	1	opin biol	PERSON
dpc-4893	47	1	2019;19:855–861	CARDINAL
dpc-4893	48	1	10.1080/14712598	CARDINAL
dpc-4893	49	1	pmid	PERSON
dpc-4893	49	2	31140882	DATE
dpc-4893	50	1	2	CARDINAL
dpc-4893	50	2	brodalumab	PERSON
dpc-4893	50	3	3 years	DATE
dpc-4893	50	4	italian	NORP
dpc-4893	52	1	10.3389	CARDINAL
dpc-4893	53	1	37469659	DATE
dpc-4893	54	1	1	CARDINAL
dpc-4893	55	1	pasi 75,	PERSON
dpc-4893	55	2	90	DATE
dpc-4893	55	3	100	CARDINAL
dpc-4893	55	4	4	CARDINAL
dpc-4893	55	5	16	DATE
dpc-4893	55	6	24 weeks	DATE
dpc-4893	56	1	3	CARDINAL
dpc-4893	56	2	galluzzo m	PERSON
dpc-4893	56	3	guselkumab	PERSON
dpc-4893	56	4	up to 148 weeks	DATE
dpc-4893	57	1	opin biol	PERSON
dpc-4893	58	1	2023;23:371–381	CARDINAL
dpc-4893	60	1	36971507	DATE
dpc-4893	61	1	4	CARDINAL
dpc-4893	61	2	mastorino l	FAC
dpc-4893	61	3	risankizumab	PERSON
dpc-4893	61	4	week 52	DATE
dpc-4893	63	1	2022;35	CARDINAL
dpc-4893	64	1	10.1111	CARDINAL
dpc-4893	65	1	35156278	DATE
dpc-4893	66	1	5	CARDINAL
dpc-4893	67	1	wang j	PERSON
dpc-4893	67	2	yu y	PERSON
dpc-4893	67	3	liu l	PERSON
dpc-4893	68	1	the past two decades	DATE
dpc-4893	69	1	autoimmun rev	PERSON
dpc-4893	70	1	2024	CARDINAL
dpc-4893	70	2	10.1016	CARDINAL
dpc-4893	71	1	pmid	PERSON
dpc-4893	71	2	39009055	DATE
dpc-4893	72	1	6	CARDINAL
dpc-4893	72	2	italian	NORP
dpc-4893	74	1	2023;10:1243843	TIME
dpc-4893	74	2	10.3389	CARDINAL
dpc-4893	75	1	pmid	PERSON
dpc-4893	75	2	37614958	DATE